Category: News

Physicians call for clinical application of “helpful, meaningful” AMPREDICT decision support tool

Researchers have found that the AMPREDICT decision support tool (DST) demonstrates “strong usability characteristics and clinical relevance” in amputation level decision-making for patients with chronic limb-threatening ischaemia (CLTI). Daniel C Norvell (VA Puget Sound Health Care System, Seattle, USA) and colleagues suggest in an online European Journal of Vascular and Endovascular Surgery (EJVES) article that, […]

The post Physicians call for clinical application of “helpful, meaningful” AMPREDICT decision support tool appeared first on Vascular News.

AngioDynamics receives 510(k) clearance for AlphaVac mechanical thrombectomy system

AngioDynamics recently announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the AlphaVac mechanical thrombectomy system. According to a company press release, AlphaVac is an off-circuit, multipurpose mechanical aspiration thrombectomy device for the non-surgical removal of thrombi or emboli from the vasculature. AngioDynamics continues to anticipate the commercial […]

The post AngioDynamics receives 510(k) clearance for AlphaVac mechanical thrombectomy system appeared first on Vascular News.

Pivotal study of TripleMed’s AneuFix device for type II endoleak enrols first 13 patients

TripleMed BV recently announced an enrolment update regarding the pivotal clinical study of the company’s AneuFix product for the treatment of type II endoleaks. According to a TripleMed press release, 13 patients have been successfully treated with AneuFix without any major complications. The company plans to enrol a total of 25 patients across six hospitals […]

The post Pivotal study of TripleMed’s AneuFix device for type II endoleak enrols first 13 patients appeared first on Vascular News.

Philips SmartCT application software receives FDA 510(k) clearance

Royal Philips today announced US Food and Drug Administration (FDA) 510(k) clearance for its Philips SmartCT application software. SmartCT is a key component of Philips’ image guided therapy system—Azurion—providing interventionalists with computed tomography (CT)-like three-dimensional (3D) images (cone beam CT) to support diagnosis, therapy planning, treatment, and follow-up for interventional radiology procedures.  Bringing intuitive […]

The post Philips SmartCT application software receives FDA 510(k) clearance appeared first on Vascular News.

Prytime Medical closes US$6 million funding round to support commercialisation growth

Prytime Medical has announced the closing of a US$6 million inside financing round to support commercialisation of its resuscitative endovascular balloon occlusion of the aorta (REBOA) haemorrhage control products. “REBOA is different now,” said Andrew Holman, chief commercialisation officer at Prytime. “Our new Plus and Pro catheters include many new technical advancements that are enabling a surge […]

The post Prytime Medical closes US$6 million funding round to support commercialisation growth appeared first on Vascular News.

Philips announces positive two-year data from TOBA II BTK clinical trial

Royal Philips recently announced positive two-year results from the TOBA (Tack optimised balloon angioplasty) II below-the-knee (BTK) clinical trial. The data show the Philips Tack endovascular system (4F), a first-of-its kind dissection repair device, provides a sustained treatment effect and positive impact on quality of life for peripheral arterial disease (PAD) and chronic limb-threatening ischaemia […]

The post Philips announces positive two-year data from TOBA II BTK clinical trial appeared first on Vascular News.